CATC 65.75   -0.750 -1.10% Updated: 04-18-2017 $CATC

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
80
CATC 65.75   -0.750 -1.10% Updated: 04-18-2017 $CATC
Last Trade: 4/18/2017 3:31:00 PM
Last 65.75   -0.750 -1.10%
Open 66.00
Previous Close 66.50
Day High / Low 66.00 / 65.75
Year High / Low 52.40 / 42.00
Volume 300
Projected Volume 300 (7%)
# of Trades / Projected 2 / 2
Dividend / Yield 1.81 / 3.95%
Abnormal Activity ABNORMAL DAY DOWN
Abnormal Volume NO
Gap NONE
Candle BEARISH
Volatility Today MEDIUM
Volatility Yesterday MEDIUM
Price Relativity
From 40 Day High 99%
From 80 Day High 98%
From 150 Day High 98%
From 40 Day Low 103%
From 80 Day Low 108%
From 150 Day Low 139%
Pivot Analysis
Price Pivot $ 65.83
Day Resistance 1 $ 65.92
Day Support 1 $ 65.67
Day Resistance 2 $ 66.08
Day Support 2 $ 65.58
Consolidations
Short Term NO
Medium Term YES
Long Term YES
Volume Indicators
20 Day Avg Vol 4,557
Today / 20 Day Avg Vol BELOW
150 Day Avg Vol 3,340
Today / 150 Day Avg Vol BELOW
Abnormal Volume NO
William Volume Accumulation bullish
Volume Price Trend bullish
Momentum Indicators
10 Day Trend bullish
40 Day Trend bullish
100 Day Trend bullish
Stochastics bearish
RSI bearish
MACD bullish
Moving Average Indictors
15 Day Trend bullish
45 Day Trend bullish
100 Day Trend bullish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? ABNORMAL DAY DOWN
Volatility Index Today MEDIUM
Volatility Index Yesterday MEDIUM
10 Day Volatility INCREASING
20 Day Volatility DECREASING
40 Day Volatility DECREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Nokia Corporation's Recent Management Transaction Highlights

Updated Category News Views 135

Nokia Corporation's Latest Management Transactions Nokia Corporation has recently announced significant management transactions that emphasize its ongoing operational strategies and technological innovations. Today, we dive into the details of one particular transaction involving a key manager in the company. Transaction Details This transaction notification is made under...

Continue Reading
Huawei's Innovative AI WAN Solution Revolutionizes Networking

Updated Category News Views 262

Huawei's New AI WAN Solution Unveiled At the Mobile World Congress in Barcelona, Huawei introduced the AI WAN Solution, a groundbreaking development designed to revolutionize networking. Leon Wang, the President of Huawei's Data Communication Product Line, emphasized the importance of merging AI with network infrastructures. This new solution aims to enhance IP networks...

Continue Reading
Transforming Business Dreams with Innovative Software Solutions

Updated Category News Views 114

Transforming Business Dreams with Innovative Software Solutions FM, a pioneer in custom software development augmented by AI technology, is revolutionizing how businesses approach growth and scalability. In a rapidly changing landscape, where adaptability is key, FM’s approach enables organizations to leverage generative software solutions that are more accessible than...

Continue Reading
Investment in Caesars Palace Times Square Promises Growth

Updated Category News Views 171

Community Investment and Support for Caesars Palace Times Square During a recent public hearing, community support was overwhelmingly evident for the Caesars Palace Times Square project. Local residents, small business owners, union workers, and city leaders gathered to express their enthusiasm for a project that promises to generate significant economic growth and create...

Continue Reading
Aquestive Therapeutics Reaches Milestone with FDA Notification

Updated Category News Views 114

Groundbreaking News from Aquestive Therapeutics Aquestive Therapeutics, Inc. (NASDAQ: AQST), a forward-thinking pharmaceutical company dedicated to enhancing patient care through innovative drug delivery solutions, has officially received word from the U.S. Food and Drug Administration (FDA) that no advisory committee meeting will be required for the New Drug Application...

Continue Reading